Nirmidas Biotech, founded in 2013 by Prof. Hongjie Dai of Stanford University, specializes in developing cutting-edge tools and reagents for life science research and clinical applications. The company is known for its pGOLD COVID-19 assays, MidaScan imaging products, and breakthrough near-infrared technologies.
As a member of prestigious programs like Janssen Labs and Stanford StartX Med, Nirmidas Biotech has been at the forefront of innovation in bioimaging and diagnostics. With a focus on NIR-I and NIR-II technologies, Nirmidas continues to advance the field of biotechnology with a mission inspired by the myth of King Midas's golden touch.
Generated from the website